Shenzhen Wingor Biotechnology Co., Ltd.
PrivateLast Round
Early Funding
Aug 25, 2025
Est. Valuation
$18.27M
Total Funding Raised
$8.25M
Company Overview
Shenzhen Wingor Biotechnology Co., Ltd. is a biotechnology company that specializes in the research, development, and commercialization of innovative cell and gene therapies, including stem cell and immune cell-based drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen Wingor Biotechnology Co., Ltd. Comparables
Compare Shenzhen Wingor Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen Beike Biotechnology Co., Ltd. | 81% | |
| Shanghai Stexo Biotechnology Co., Ltd. | 79% | |
| Help Therapeutics | 78% |
Shenzhen Wingor Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 25, 2025 | ||||
| Series A | Nov 1, 2021 | ||||
| Strategic | Apr 1, 2021 | ||||
| Strategic | Feb 4, 2019 |
Shenzhen Wingor Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2025
Company has raised an early funding round.
- Nov 1, 2021
Raised Series A led by Oriental Fortune Capital and Hanshang Group.
Shenzhen Wingor Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shenzhen Wingor Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Shenzhen Wingor Biotechnology Co., Ltd. a public or private company?
Shenzhen Wingor Biotechnology Co., Ltd. is a private company.
What is the current stock price of Shenzhen Wingor Biotechnology Co., Ltd.?
Shenzhen Wingor Biotechnology Co., Ltd. is a private company with no public stock price. Caplight tracks Shenzhen Wingor Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Shenzhen Wingor Biotechnology Co., Ltd. worth (valuation)?
Shenzhen Wingor Biotechnology Co., Ltd.'s valuation is estimated at $18.3M based on funding round data.
Can I buy Shenzhen Wingor Biotechnology Co., Ltd. stock?
Shenzhen Wingor Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shenzhen Wingor Biotechnology Co., Ltd.'s last funding round?
Shenzhen Wingor Biotechnology Co., Ltd.'s most recent funding round was Early Funding on February 4, 2019.
Who are the main investors in Shenzhen Wingor Biotechnology Co., Ltd.?
Key investors in Shenzhen Wingor Biotechnology Co., Ltd. include Oriental Fortune Capital.
Will Shenzhen Wingor Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shenzhen Wingor Biotechnology Co., Ltd..
How can I track Shenzhen Wingor Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shenzhen Wingor Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.